Other Events ·
BioHarvest Sciences registers 27.2M shares for dual listing on Tel Aviv Stock Exchange
BHSTBioharvest Sciences Inc.
BioHarvest Sciences Inc. announced the registration of its common shares on the Tel Aviv Stock Exchange (TASE), achieving dual listing alongside its existing Nasdaq Capital Market listing. Trading on TASE commenced on September 8, 2026, under the symbol BHST. The company registered approximately 22.7 million outstanding shares for trading, along with up to 4.5 million additional shares available for future issuance under equity incentive plans and warrants. This expansion provides investors in Israel with direct access to the company's equity. BioHarvest Sciences Inc. operates in the biotechnology industry, focusing on the development of plant-based therapeutics.